| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO, Valence Health | Chief Development Officer
1 company
Wigginton Steve is a CEO, Valence Health at EVH. Recent filings cover 0 purchases and 14 sales. Those positions are worth an estimated $57K at current prices.
Wigginton Steve's largest disclosed position is in EVH as CEO, Valence Health, worth about $57K. The recent filings there lean toward selling, a net 109,347 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2016 | EVH Evolent Health, Inc. | Chief Development Officer | Sell | 45,760 | $21.54 | $985,670.40 | -11.3% |